Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
INTERVENTIONAL
Inicio: 30 de jun de 2007
ID: NCT00423891
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma and Complete Radiological Response After Surgical Resection or Local Ablation (KEYNOTE-937)
INTERVENTIONAL
Inicio: 28 de may de 2019
ID: NCT03867084
Completado
Fase 4
ClinicalTrials.gov
A Single-arm, Multinational, Two Year Study Evaluating the Efficacy and Safety of lead-in Telbivudine for 24 Weeks With or Without Tenofovir Treatment Intensification in Adult Patients With HBeAg-positive Chronic Hepatitis B.
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT00651209
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma That Has Progressed After Prior VEGFR Tyrosine Kinase Inhibitor Therapy
INTERVENTIONAL
Inicio: 1 de jun de 2013
ID: NCT01865747
Desconocido
ClinicalTrials.gov
GastroBot: a New Artificial Intelligence-developed Software Bot to Improve Bowel Preparation and Colonoscopy Quality
INTERVENTIONAL
Inicio: 1 de ene de 2024
ID: NCT05836064
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Platform Study Evaluating the Efficacy and Safety of Interventions in Participants With Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 23 de sept de 2019
ID: NCT04102111
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Group Study of the Safety and Effect on Clinical Outcome of Tocilizumab SC Versus Tocilizumab IV, in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs), in Patients With Moderate to Severe Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01194414
Terminado
Fase 3
ClinicalTrials.gov
Randomized Phase III Trial Comparing Nilotinib 800mg to Imatinib 800 mg for the Treatment of Patients With Advanced and/or Metastatic Gastrointestinal Stromal Tumors Refractory to Imatinib 400 mg
INTERVENTIONAL
Inicio: 1 de jun de 2009
ID: NCT00751036
Terminado
ClinicalTrials.gov
Fungal Fiber for Gut Health
INTERVENTIONAL
Inicio: 3 de may de 2024
ID: NCT06404749
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 26 de sept de 2016
ID: NCT02819635
Reclutando
ClinicalTrials.gov
Observational Study, for Quality Assessment, of Sarcoma As a Model to Improve Diagnosis and Clinical Care of Rare Tumors Through a European and Latin American Multidisciplinary NETWORK
OBSERVATIONAL
Inicio: 30 de jun de 2019
ID: NCT04181970
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 5 de sept de 2019
ID: NCT03950232
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan Versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First Line Treatment of HER2-positive Gastric Cancer (ARTEMIDE-Gastric01)
INTERVENTIONAL
Inicio: 1 de mar de 2025
ID: NCT06764875
Completado
ClinicalTrials.gov
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT01192412
Terminado
Fase 1
ClinicalTrials.gov
A Phase 1, Multicenter, Open-label Study to Evaluate the Pharmacokinetics of CC-486 (Onureg®) in Subjects With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Adult Subjects With Myeloid Malignancies
INTERVENTIONAL
Inicio: 12 de jul de 2024
ID: NCT05209295
Completado
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering From Irritable Bowel Syndrome With Diarrhea
INTERVENTIONAL
Inicio: 1 de feb de 2017
ID: NCT04627337
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multi-center Phase III Study of Brivanib Versus Sorafenib as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00858871
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
INTERVENTIONAL
Inicio: 29 de nov de 2017
ID: NCT03345836
Desconocido
ClinicalTrials.gov
Efficacy of a Mobile Clinical Decision Support System (CaPtyVa CCR App) to Improve Performance of Gastroenterology and Coloproctology Specialists in Colorectal Cancer Screening and Surveillance According to Guideline Recommendations: A Randomized Clinical Trial.
INTERVENTIONAL
Inicio: 15 de may de 2020
ID: NCT04389502
Reclutando
ClinicalTrials.gov
Role of Mucosal Impedance Measurement for the Diagnosis of Gastroesophageal Reflux Disease
OBSERVATIONAL
Inicio: 12 de dic de 2024
ID: NCT06339801
Anterior
1
...
17
18
19
...
434
Siguiente
Filtros